FRANCISCO
VIVES MONTERO
Investigador desde 2023
Hospital Universitario San Cecilio
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (14)
2022
-
Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome
International Journal of Molecular Sciences, Vol. 23, Núm. 19
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2019
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2016
-
Analysis of the genetic variability in Parkinson's disease from Southern Spain
Neurobiology of Aging, Vol. 37, pp. 210.e1-210.e5
-
Genome-wide assessment of Parkinson's disease in a Southern Spanish population
Neurobiology of Aging, Vol. 45, pp. 213.e3
2014
-
Proteomic biomarkers in Parkinson's disease
Revista de Neurologia, Vol. 58, Núm. 4, pp. 166-174
2011
-
Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment
Neurodegenerative Diseases, Vol. 8, Núm. 3, pp. 109-116
2010
-
Plasma α-synuclein in patients with Parkinson's disease with and without treatment
Movement Disorders, Vol. 25, Núm. 4, pp. 489-493
2006
-
Evaluation of the Spanish version of the Memory Impairment Screen
Revista de Neurologia, Vol. 43, Núm. 1, pp. 15-19
-
Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa
Journal of the Neurological Sciences, Vol. 240, Núm. 1-2, pp. 31-36
2005
-
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
Pharmacogenomics Journal, Vol. 5, Núm. 2, pp. 135-141
-
Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome
Journal of Neural Transmission, Vol. 112, Núm. 10, pp. 1345-1353